Bristol-Myers Squibb
BMY
#190
Rank
โ‚ฌ94.56 B
Marketcap
46,45ย โ‚ฌ
Share price
1.42%
Change (1 day)
-18.68%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): 2,62ย โ‚ฌ

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is 2,51ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,73ย โ‚ฌ a decrease over its 2023 EPS that were of 3,27ย โ‚ฌ.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)2,62ย โ‚ฌ-170.25%
2024-3,73ย โ‚ฌ-213.92%
20233,27ย โ‚ฌ30.2%
20222,51ย โ‚ฌ-6.04%
20212,68ย โ‚ฌ-179.29%
2020-3,38ย โ‚ฌ-281.37%
20191,86ย โ‚ฌ-27.21%
20182,56ย โ‚ฌ
20162,25ย โ‚ฌ175.26%
20150,82ย โ‚ฌ-19.83%
20141,02ย โ‚ฌ-22.44%
20131,32ย โ‚ฌ34.48%
20120,98ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
8,81ย โ‚ฌ 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,21ย โ‚ฌ 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,45ย โ‚ฌ-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,14ย โ‚ฌ-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
17,31ย โ‚ฌ 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
10,99ย โ‚ฌ 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,13ย โ‚ฌ 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
9,27ย โ‚ฌ 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,41ย โ‚ฌ 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
2,56ย โ‚ฌ 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK